GSK and Vir Biotechnology expand coronavirus collaboration

GSK and Vir Biotechnology expand coronavirus collaboration

GlaxoSmithKline plc (GSK) and Vir Biotechnology, Inc. have entered into an agreement to expand their existing collaboration to include the research and development of...
Partnership to ensure seamless dispensing between pharmacies and care homes

New partnership ensures dispensing between pharmacies and care homes is seamless

MED e‐care and Cegedim have announced a new partnership to integrate Cegedim’s Pharmacy Manager with MED e‐care’s electronic Medication Administration Record (eMAR). The integration of...
Positive phase III results for Lilly’s tirzepatide in type 2 diabetes

Positive phase III results for Lilly’s tirzepatide in type 2 diabetes

Lilly has announced positive first data from two phase III trials, showing that tirzepatide led to significant reductions in HbA1c and body weight reductions...
MHRA launches public consultation on two contraceptive pills

MHRA launches public consultation on two contraceptive pills

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a public consultation on the reclassification of two progestogen-only contraceptive pills containing desogestrel. The consultation...
New Vice President for Leo Pharma

LEO Pharma appoints new Vice President

LEO Pharma has appointed Sarah Kleinpeter as Vice President of UK and Ireland, succeeding the outgoing Vice President and Managing Director Geraldine Murphy, who...
Positive phase III data for Roche’s vision loss therapy

Positive phase III data for Roche’s vision loss therapy

New phase III data show Roche’s faricimab is the first investigational injectable eye medicine to extend time between treatments up to four months in...
Sandoz acquires GSK’s cephalosporin antibiotics business

Sandoz acquires GSK’s cephalosporin antibiotics business

Sandoz has signed an agreement to acquire GSK’s cephalosporin antibiotics business, which includes the global rights to three established brands (Zinnat®, Zinacef® and Fortum®)...
Blueprint launched for NHS reform following COVID-19 pandemic

Blueprint launched for NHS reform following COVID-19 pandemic

The Health and Social Care Secretary, with the support of NHS England and health and care system leaders, will today set out new proposals...
NIHR funds study to improve the lives of people with cystic fibrosis

NIHR funds study to improve the lives of people with cystic fibrosis

The NIHR has awarded funding to the University of Liverpool and Alder Hey Children’s Hospital to conduct a trial to improve the lives of...
World’s first clinical trials of COVID-19 vaccine combination announced

World’s first clinical trials of COVID-19 vaccine combination

In a bid to combat future mutations of COVID-19, a joint research programme will begin in February 2021 to assess the immunogenicity and safety...

Latest articles

COVID-19 one year on - key changes

COVID-19 and key changes one year on

One year on from the first confirmed case of COVID-19 in the UK, Oli Hudson, Content Director at Wilmington Healthcare, takes a look at...
FDA approval for Roche’s Actemra/RoActemra in lung disease

FDA approves Roche’s Actemra/RoActemra for interstitial lung disease

Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Actemra®/RoActemra® (tocilizumab) subcutaneous injection for slowing the rate of decline in...
Pre-clinical work completed for novel COVID-19 immunotherapy

Pre-clinical work completed for novel COVID-19 immunotherapy

ISA Pharmaceuticals has announced that it has completed pre-clinical work for ISA106, a novel COVID-19 immunotherapy and is planning clinical trials. A phase 1...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
NHS prescription charge to increase from 1st April

NHS prescription charge to increase from 1 April 2021

The NHS prescription charge will increase to £9.35 per prescription item from 1 April 2021 in England, according to the Pharmaceutical Services Negotiating Committee...
Nasal spray to protect against COVID-19 is ready for use in humans

Nasal spray to protect against COVID-19 is ready for use in humans

A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...

Pancreatic Cancer Story: James Dadge

James, 44, lives in Manchester with his partner Andrea and sons Ben and Daniel. He was diagnosed with a neuroendocrine tumour, with the primary...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription